Serum soluble urokinase plasminogen activator receptor (suPAR) in adults with growth hormone deficiency

Growth hormone deficiency (GHD) syndrome is associated with adverse levels of several risk factors for cardiovascular diseases (CVD), including metabolic inflammation. However, the impact of GHD and GH treatment on low-grade inflammation is unknown. The aim of the study was to establish the level of...

Descripción completa

Detalles Bibliográficos
Autores principales: Höybye, Charlotte, Faseh, Laia, Himonakos, Christos, Pielak, Tomasz, Eugen-Olsen, Jesper
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6547304/
https://www.ncbi.nlm.nih.gov/pubmed/31151091
http://dx.doi.org/10.1530/EC-19-0159

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6547304/
https://www.ncbi.nlm.nih.gov/pubmed/31151091
http://dx.doi.org/10.1530/EC-19-0159

Ejemplares similares